Trial NCT02205333

View at ClinicalTrials.gov 
Org. Study IDs: D4981C00001

Last trial update was posted on 2017-06-28

MeSH Interventions

Durvalumab Rituximab Tremelimumab

MeSH Conditions

Aggression Lymphoma Lymphoma, B-Cell

Other Conditions

Advanced Solid Tumors Aggressive B-cell Lymphomas

Stopping Reasons

The study was terminated early at the sponsor's discretion.

Limitations And Caveats

The study was terminated early at the Sponsor's discretion.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID